Atlas Trials

A Prospective Phase II Study for Adjuvant Hypofractionated Intensity-modulated Proton Radiotherapy for Post Operative Breast Cancer With Implantation Reconstruction

Clinical trial NCT05692674 · RECRUITING

Trial details

NCT number
NCT05692674
Sponsor
Shanghai Proton and Heavy Ion Center
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Breast Cancer
Start date
2023-01-10
Primary completion
2028-09-01
Enrollment
67

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.